| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7504059 | Drug and Alcohol Dependence | 2016 | 6 Pages |
Abstract
Ibudilast appeared to reduce reward-related subjective effects of MA in this early-stage study, possibly due to altering the processes of neuroinflammation involved in MA reward. Given this novel mechanism of action and the absence of an efficacious medication for MA dependence, ibudilast warrants further study to evaluate its clinical efficacy.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Matthew J. Worley, Keith G. Heinzerling, Daniel J.O. Roche, Steve Shoptaw,